Analysis of drug sensitivity data from 61 lung adenocarcinoma cell lines in the GDSC database revealed that cell lines with ATM mutation were significantly more sensitive to olaparib than those with wild-type ATM (Fig. 1a). This evidence concerns the gene ATM and lung adenocarcinoma.